We will have to see the fine print if there is anything for pharma
Kiran Mazumdar Shaw, Chairperson, Biocon, and Biocon Biologics, shares her reaction to the union budget 2022 released today
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Kiran Mazumdar-Shaw
Pharma veterans discuss ideas for building successful companies at IIMPACT HEALTH 2021
The experts deliver learnings, takeaways and way forward for pharma industry
Biocon Q1FY22 revenue at Rs 1,808 crores, up six per cent
Biosimilars up 10 per cent at Rs 758 crores and research services up 41 per cent at Rs 595 crores
G S Krishnan is the new President of ABLE
Krishnan will head a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021
Biocon Biologics promotes Shreehas Tambe to deputy chief executive officer
Biocon Biologics announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon…
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30…
Biocon Biologics, a subsidiary of
Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand…
Biocon Biologics inducts Professor Peter Piot to its Board as Independent Director
Professor Piot is the Director of the London School of Hygiene & Tropical Medicine and the Handa Professor of Global Health
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health…
The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias
Abu Dhabi firm, ADQ invests Rs 555 crores in Biocon Biologics
Biocon Biologics had raised over $255 million from global investors from Jan to Nov 2020
Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs
Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion